Secondary mapping of lymphatic filariasis in Haiti-definition of transmission foci in low-prevalence settings.
To eliminate Lymphatic filariasis (LF) as a public health problem, the World Health Organization (WHO) recommends that any area with infection prevalence greater than or equal to 1% (denoted by presence of microfilaremia or antigenemia) should receive mass drug administration (MDA) of antifilarial d...
Guardado en:
Autores principales: | Naomi Drexler, Charles H Washington, Maribeth Lovegrove, Caroline Grady, Marie Denise Milord, Thomas Streit, Patrick Lammie |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3876f7f3051146468da6aeb337be5499 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Global elimination of lymphatic filariasis: a "mass uprising of compassion".
por: David G Addiss
Publicado: (2013) -
Lymphatic filariasis elimination in the Dominican Republic: History, progress, and remaining steps.
por: Manuel Gonzales, et al.
Publicado: (2021) -
The emerging story of disability associated with lymphatic filariasis: a critical review.
por: Lynne Michelle Zeldenryk, et al.
Publicado: (2011) -
The wider societal benefits of surgical interventions for lymphatic filariasis morbidity management and disability prevention.
por: Sarah Martindale, et al.
Publicado: (2021) -
Assessing factors influencing communities' acceptability of mass drug administration for the elimination of lymphatic filariasis in Guyana.
por: Reza A Niles, et al.
Publicado: (2021)